These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2754805)

  • 21. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
    Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
    Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differential determination of fibrinogen degradation products in assessment of the stages of plasma consumption in patients with infection and liver cirrhosis].
    Raschka C; Róka L
    Leber Magen Darm; 1993 Jan; 23(1):31-4. PubMed ID: 8445974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum FDP assay with latex photometric immunoassay and its analysis by immunoblotting].
    Okumura N; Kagiya H; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1991 Jan; 39(1):76-82. PubMed ID: 2008047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunochemical model for the agglutination reaction of FR antigens in a new latex photometric immunoassay with near infrared turbidimetry.
    Sudo T; Tsutsui S; Ito M; Morita S; Sawai M
    Kitasato Arch Exp Med; 1980 Jun; 53(1-2):55-68. PubMed ID: 7277958
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of the use of glutaraldehyde for the sensitization of red cells in Merskey's technic].
    Quichaud C; de Cacqueray-Joigny C; Etcharry F; Moras M; Chatelan M; Boisseau M; Bentegeat J
    Pathol Biol (Paris); 1974 Nov; 22 suppl():92-6. PubMed ID: 4219981
    [No Abstract]   [Full Text] [Related]  

  • 28. D-dimer determination to exclude pulmonary embolism: a two-step approach using latex assay as a screening tool.
    de Moerloose P; Minazio P; Reber G; Perrier A; Bounameaux H
    Thromb Haemost; 1994 Jul; 72(1):89-91. PubMed ID: 7974382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical comparison of AxSYM, HemosIL DD HS and Innovance D-dimer immunoassays with the Vidas D-dimer.
    Salvagno GL; Lippi G; Manzato F; Giavarina D; Montagnana M; Poli G; Guidi GC
    Int J Lab Hematol; 2009 Aug; 31(4):475-7. PubMed ID: 18503567
    [No Abstract]   [Full Text] [Related]  

  • 30. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Distinction between fibrinogen and fibrin degradation products in serum from patients with DIC (author's transl)].
    Yoshioka K; Yamamoto T; Yamauchi E; Mizuno S; Miyata H
    Rinsho Ketsueki; 1981 Sep; 22(9):1401-5. PubMed ID: 7334618
    [No Abstract]   [Full Text] [Related]  

  • 32. A clinical evaluation of Thrombo-Wellcotest as a screening test for D.I.C.
    Song KS; Ahn YM; Kim HS; Lee SY
    Yonsei Med J; 1980; 21(1):58-61. PubMed ID: 7269637
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessing fibrin-split products.
    Norris MK
    Nursing; 1992 Jun; 22(6):29. PubMed ID: 1614647
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical implications of analyses of fibrinogen and fibrin-derivatives in DIC].
    Magari Y; Ito M; Itoga T
    Rinsho Ketsueki; 1986 Oct; 27(10):1992-2007. PubMed ID: 3820619
    [No Abstract]   [Full Text] [Related]  

  • 35. Fibrin degradation products in the postoperative period. Evaluation of a new latex agglutination method.
    Smith RT; Ts'ao CH
    Am J Clin Pathol; 1973 Nov; 60(5):644-7. PubMed ID: 4201627
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relationship between the plasma levels of soluble fibrin monomer and the formation of soluble fibrin monomer complex (SFMC)].
    Okajima K; Okabe H; Kumagai T; Yang WP; Maeda M; Miyagawa S; Watanabe E; Yoshimi K; Koga S; Takatsuki K
    Rinsho Byori; 1989 Apr; 37(4):411-5. PubMed ID: 2787429
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of fibrinogen disintegration in the central retinal vein thrombosis and some other visual conditions].
    Maciejasz A; Grzadzielska E
    Klin Oczna; 1976; 46(12):1415-9. PubMed ID: 1011672
    [No Abstract]   [Full Text] [Related]  

  • 38. Validation of an Automated Immunoturbidimetric Assay for Fibrinogen/Fibrin Degradation Products Measurement and its Correlation to a Semi-Quantitative Latex Agglutination Test.
    Martinuzzo ME; Ujhelly C; Barrera LH; Adamo MA; Lopez MS; Otaso JC; Oyhamburu J
    Clin Lab; 2016 Nov; 62(11):2085-2089. PubMed ID: 28164666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assays for fibrinogen-fibrin degradation products in biological fluids: some methodological aspects.
    Donati MB
    Thromb Diath Haemorrh; 1975 Dec; 34(3):652-60. PubMed ID: 1108282
    [No Abstract]   [Full Text] [Related]  

  • 40. [FFDP (fibrin fibrinogen degradation products), D-dimers, and SFMC (soluble fibrin monomer complex)].
    Kuroso K
    Rinsho Byori; 1987 Apr; Spec No 70():224-32. PubMed ID: 3302392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.